Life Science

Sobi Opens North American Operations

(l to r) Brittany McDonough, Manager of Business Development for the Massachusetts Office of International Trade & Investment; Susan Windham-Bannister, Ph.D, President & CEO of the Massachusetts Life Sciences Center; Dr. Geoffey McDonough, Chief Executive Officer of Sobi; Rami Levin, President of Sobi, Inc. North America; Dr. Peter Saltonstall, President of the National Organization of Rare Disorders; and Peter Abair, Director of Economic Development & Global Affairs for MassBio celebrate the opening of Sobi’s new North America Headquarters in Waltham, Massachusetts.

(l to r) Brittany McDonough, Mass. Office of International Trade & Investment; Susan Windham-Bannister, Ph.D, president and CEO of MLSC; Dr. Geoffey McDonough, CEO of Sobi; Rami Levin, president of Sobi, North America; Dr. Peter Saltonstall, National Organization of Rare Disorders; and Peter Abair, MassBio.

Waltham, MA – Swedish Orphan Biovitrum AB (publ) (Sobi) formally opened the company’s new North American headquarters in Waltham with a ribbon-cutting ceremony arranged in collaboration with the Massachusetts Life Sciences Center (MLSC).

“North America is an increasingly important region for Sobi, and building our team in the Boston area supports us in our efforts to better address the needs of patients and healthcare providers throughout the United States and Canada,” said Geoffrey McDonough, president and CEO of Sobi. ”We are delighted to partner and collaborate with the Massachusetts Life Sciences Center as we build and grow in the years to come.”

Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In North America, the company mainly focuses on inflammatory, genetic, and metabolic diseases.

Sobi worked closely with the Massachusetts Life Sciences Center when developing plans for its Massachusetts office.

-more-

“On behalf of the Center, I would like to extend a warm welcome to the team at Sobi as they open their new North American headquarters in Waltham,” said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center, the agency charged with implementing Governor Patrick’s 10-year, $1 billion Life Sciences Initiative. “Sobi is an excellent addition to a growing cluster of Massachusetts companies that are working to improve the lives of patients with rare diseases. We are excited that Sobi has chosen Massachusetts as the home of its North American headquarters and look forward to partnering with the company as it grows.”

Ceremony attendees included MLSC President & CEO Susan Windham-Bannister, Ph.D.; President, National Organization of Rare Disorders, Dr. Peter Saltonstall; Manager of Business Development, Massachusetts Office of International Trade & Investment Brittany McDonough; MassBio Director of Economic Development & Global Affairs Peter Abair; as well as McDonough, and Sobi North America President Rami Levin.

“Thanks to our growth strategy of investing in education, innovation and infrastructure, and the extensive outreach efforts of the Massachusetts Life Sciences Center, Massachusetts has become the destination of choice for international life sciences companies that want to have a presence in the U.S. market,” said Governor Deval Patrick. “We welcome Sobi to their new offices in Waltham and look forward to partnering with them as they grow.”

Massachusetts has one of the largest concentrations of biotech activity in the world,” said Levin. “The region has established a broadbased biotech industry segment, and with Massachusetts as a major driver for global biotechnology innovation there is a strong talent pool here. This is essential for us as we grow our North American business.”

 

 

Leave a Comment

Take advantage of High-Profile’s current subscription rates now, by signing up for a monthly or annual subscription!

Learn More!